These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21333079)

  • 21. A prospective controlled trial of albuterol aerosol delivered via metered dose inhaler-spacer device (MDI) versus jet nebulizer in ventilated preterm neonates.
    Khalaf MN; Hurley JF; Bhandari V
    Am J Perinatol; 2001 May; 18(3):169-74. PubMed ID: 11414530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P; Balkovec S; Solomon M; Ratjen F
    Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does nebulized hypertonic saline shorten hospitalization in young children with acute viral wheezing?
    Kanjanapradap T; Deerojanawong J; Sritippayawan S; Prapphal N
    Pediatr Pulmonol; 2018 Feb; 53(2):138-144. PubMed ID: 29266863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE; Godovchik JE; Donn KH; Busick DR; Goralski J; Locke LW; Markovetz MR; Myerburg MM; Muthukrishnan A; Weber L; Lacy RT; Pilewski JM
    Pediatr Pulmonol; 2017 Sep; 52(9):1142-1149. PubMed ID: 28737262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchodilator response to albuterol nebulized with hypertonic saline in asthmatic children.
    Teper A; Kofman C; Alchundia Moreira J; Köhler T; García Bournissen F
    Pediatr Pulmonol; 2021 Dec; 56(12):3714-3719. PubMed ID: 34499820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R; Metcalfe C; Wallis C; Bush A
    Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhaled treatments in cystic fibrosis: what's new in 2013?].
    Dubus JC; Bassinet L; Chedevergne F; Delaisi B; Desmazes-Dufeu N; Reychler G; Vecellio L;
    Rev Mal Respir; 2014 Apr; 31(4):336-46. PubMed ID: 24750953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin.
    Vecellio L; Abdelrahim ME; Montharu J; Galle J; Diot P; Dubus JC
    J Cyst Fibros; 2011 Mar; 10(2):86-92. PubMed ID: 21075063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis.
    Laube BL; Geller DE; Lin TC; Dalby RN; Diener-West M; Zeitlin PL
    Respir Care; 2005 Nov; 50(11):1438-44. PubMed ID: 16253150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A survey of albuterol administration practices in intubated patients in the neonatal intensive care unit.
    Ballard J; Lugo RA; Salyer JW
    Respir Care; 2002 Jan; 47(1):31-8. PubMed ID: 11749685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertonic saline treatment of cystic fibrosis.
    Taylor LM; Kuhn RJ
    Ann Pharmacother; 2007 Mar; 41(3):481-4. PubMed ID: 17327291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
    Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
    J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis.
    König P; Goldstein D; Poehlmann M; Rife D; Ge B; Hewett J
    Pediatr Pulmonol; 2005 Aug; 40(2):105-8. PubMed ID: 15965894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised controlled trial of breathing modes for adaptive aerosol delivery in children with cystic fibrosis.
    McCormack P; McNamara PS; Southern KW
    J Cyst Fibros; 2011 Sep; 10(5):343-9. PubMed ID: 21620782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial of nebulized 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department.
    Grewal S; Ali S; McConnell DW; Vandermeer B; Klassen TP
    Arch Pediatr Adolesc Med; 2009 Nov; 163(11):1007-12. PubMed ID: 19884591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis].
    Máiz Carro L; Lamas Ferreiro A; Ruiz de Valbuena Maiz M; Wagner Struwing C; Gabilondo Álvarez G; Suárez Cortina L
    Med Clin (Barc); 2012 Feb; 138(2):57-9. PubMed ID: 21511313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and safety of tobramycin administered by the PARI eFlow rapid nebulizer in cystic fibrosis.
    Hubert D; Leroy S; Nove-Josserand R; Murris-Espin M; Mely L; Dominique S; Delaisi B; Kho P; Kovarik JM
    J Cyst Fibros; 2009 Sep; 8(5):332-7. PubMed ID: 19651542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.